Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

MicroRNAs

MicroRNAs

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advances in Immunological Methods for the Detection of <i>Escherichia coli</i> O157:H7: A Review.

Sensors (Basel, Switzerland)·2026

Same author

A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade®).

Journal of controlled release : official journal of the Controlled Release Society·2026

Same author

Development and Clinical Validation of an Artificial Intelligence-Based Automated Visual Acuity Testing System.

Life (Basel, Switzerland)·2026

Same author

Cyclic Polyesters: Synthetic Methods and Perspectives.

Chemistry, an Asian journal·2025

Same author

Nanoparticle Adjuvant Design Enhances Germinal Center Responses Targeting Conserved Subdominant Epitopes for Pan-Coronavirus Vaccine Development.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Same author

The Survival for Pneumonectomy After Neoadjuvant Therapy in Non-small Cell Lung Cancer: A Retrospective Study from the National Cancer Center in China.

Annals of surgical oncology·2025

Search research articles

Related Experiment Video

Updated: Mar 25, 2026

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

MicroRNAs in diffuse large B-cell lymphoma.

Huiyun Ni¹, Rong Tong¹, Linqing Zou²

¹Department of Hematology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.

Oncology Letters

|February 20, 2016

Summary

Aberrant microRNA (miR) expression impacts lymphocyte biology and diffuse large B-cell lymphoma (DLBCL) development. Specific miR signatures aid in DLBCL subtyping, prognosis, and distinguishing it from other lymphomas.

Keywords:

diagnosis diffuse large B-cell lymphoma microRNAs prognosis regulator gene therapeutic targets

More Related Videos

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Experiment Videos

Last Updated: Mar 25, 2026

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

Aberrant microRNA (miR) expression significantly influences lymphocyte biology.
miRs play a crucial role in the pathogenesis of diffuse large B-cell lymphoma (DLBCL).

Purpose of the Study:

To review the aberrant expression of miRs in DLBCL.
To discuss the functions, clinical utility, and therapeutic potential of miRs in DLBCL.

Main Methods:

miR profiling to identify distinct miR signatures.
Analysis of existing literature on miR roles in DLBCL.

Main Results:

Specific miR signatures can accurately distinguish DLBCL subtypes and prognostic classifications.
miRs can differentiate DLBCL from indolent lymphomas like follicular lymphoma.
miR expression profiles in patient tissues correlate with prognosis and clinical outcomes.

Conclusions:

miRs are valuable biomarkers for DLBCL diagnosis and prognosis.
Further research into miRs offers potential for novel therapeutic strategies in DLBCL.